Skip to main content
Have a personal or library account? Click to login
An Evaluation of Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic and Prognostic Biomarkers of Severe Sepsis Cover

An Evaluation of Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic and Prognostic Biomarkers of Severe Sepsis

Open Access
|Nov 2015

References

  1. 1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10.
  2. 2. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31:946-55.
  3. 3. Bone R, Balk R, Cerra F, et al. Definitions for sepsisand organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of ChestPhysicians / Society of Critical Care Medicine”. Chest. 1992;101: 1644-55.
  4. 4. Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: Sampling, selection, and society. Crit Care. 2004;8:222-6.
  5. 5. Hervald H, Egesten A. Sepsis. Pro-Inflammatory and Anti- Inflammatory Responses. Controb Microbiol. Basel, Krager, 2011, vol 17, pp 1-11.
  6. 6. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsisand septic shock: 2012. Crit Care Med. 2013;41:580-637.
  7. 7. Giamarellos-Bourboulis EJ, Giannopoulou P, Grecka P, et al. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care. 2004; 19:152-7.
  8. 8. James D. Faix. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50:23-36.
  9. 9. Szederjesi J, Almasy E, Lazar A, Huțanu A, Georgescu A. The Role of Angiopoietine-2 in the Diagnosis and Prognosis of Sepsis. J Crit Care Med. 2015;1:18-23.
  10. 10. Schröder J, Staubach KH, Zabel P, Stüber F, Kremer B. Procalcitonin as a marker of severity in septic shock. Langenbecks Arch Surg. 1999;384:33-8.
  11. 11. Enguix-Armada A, Escobar-Conesa R, La Torre AG, De La Torre- Prados MV. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin. Clin Chem Lab Med. 2015 17. pii: /j/cclm.ahead-of-print/cclm-2015-0243/cclm-2015-0243.xml. doi: 10.1515/cclm-2015-0243. [Epub ahead of print]
  12. 12. Samraj RS, Zingarelli B, Wong HR. Role of biomarkers in sepsis care. Shock. 2013;40:358-65.
  13. 13. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ ATS/ SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31:1250-6.
  14. 14. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344-53.
  15. 15. Nargis W, Ibrahim Md, Adamed BU. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014;4:195-9.
  16. 16. Koenig SM, Truwit JD. Ventilator-Associated Pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19:637-57.
  17. 17. Magill SS, Dumyati G, Ray SM, Fridkin SK. Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States. Emerg Infect Dis. 2015;21:1537-42.
  18. 18. Que YA, Guessous I, Dupuis-Lozeron E, et al. Prognostication of Mortality in Critically Ill Patients With Severe Infections. Chest. 2015;148:674-82.
  19. 19. Enguix-Armada A, Escobar-Conesa R, La Torre AG et al. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and midregional pro-adrenomedullin. Clin Chem Lab Med. 2015. pii:/j/cclm.ahead-of-print/cclm-2015-0243/cclm-2015-0243.xml. doi: 10.1515/cclm-2015-0243. [Epub ahead of print].
  20. 20. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults. A Multicenter {rospective Study in Intensive Care Units. JAMA. 1995;274:968-74.
  21. 21. Hinriksdóttir G, Tryggvadóttir Á, Ólafsdóttir AS, et al. Fatness but Not Fitness Relative to the Fat-Free Mass Is Related to C-Reactive Protein in 18 Year-Old Adolescents. PLoS One. 2015;10:e0130597. doi: 10.1371/journal.pone.0130597. eCollection 2015.
  22. 22. Parrett AL, Valentine RJ, Arngrímsson SA et al. Adiposity, activity, fitness, and C-reactive protein in children. Med Sci Sports Exerc. 2010;42:1981-6.
  23. 23. Waheeda Nargis, Md Ibrahim, Borhan Uddin Ahamed. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit. 2014;4:195-9.
  24. 24. Akcay I, Okoh AK, Yalav O, et al. The prognostic value of procalcitonin, CRP and thyroid hormones in secondary peritonitis: a single-center prospective study. Ulus Travma Acil Cerrahi Derg. 2014;20:343-352.
DOI: https://doi.org/10.1515/jccm-2015-0022 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 147 - 153
Submitted on: Jul 16, 2015
Accepted on: Sep 1, 2015
Published online: Nov 10, 2015
Published in print: Oct 1, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Janos Szederjesi, Emoke Almasy, Alexandra Lazar, Adina Huțanu, Iudita Badea, Anca Georgescu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.